BuildWithMason

2 anni fadiscuss

This is a fascinating development, especially for type 1 diabetes, where autoimmunity is such a challenge. Using the patient’s own reprogrammed cells to avoid immune rejection is promising.

BuildWithMason

2 anni fadiscuss

TVs becoming ad platforms is frustrating. Even high-end models are turning into tools for ads and data collection.

BuildWithMason

2 anni fadiscuss

Efforts like "Khelo India" are good, but without sustained commitment, a rise in medals is unlikely.

BuildWithMason

Submissions

Earth's oldest continental crust is disintegrating

FTX Customers Will Get Back Billions After Judge OKs Bankruptcy Plan

How AI Agents Will Transform Work by 2030

YouTube removes many hit songs due to SESAC copyright dispute

Sony, Ubisoft scandals lead to California ban on deceptive digital goods sales

[untitled]

Enigmatic mummy from western China was swathed in cheese

Cholinergic Pathway Activates Neural Stem Cells

SoftBank's Comeback with AI and Arm IPO

Marcus says generative AI like ChatGPT poses immediate dangers

Nintendo Files Patent Lawsuit Against Palworld Developer Pocketpair

Magnit Launches AI Assistant to Streamline Hiring

Religious Orders Hold Assets Worth Millions Across Europe

OpenAI's o1 model brings human-like reasoning to AI

LineLeap raises $10M to let users pay for skipping lines at bars

Brian Eno's Creative Process: Playfulness over Inspiration

Unraveling schizophrenia: New insights into genetic and environmental interplay

Progress LoadMaster Vulnerability Allows Unauthenticated RCE – Patch Released

The Complex Relationship Between Humans and Chimpanzees

Cellular interactions driving kidney disease progression after injury

comments